Windtree Therapeutics

Windtree's hypertension med snarled in Catch-22 as hunt for partners comes up dry
Fierce Biotech
Wed, 07/5/23 - 10:36 am
Windtree Therapeutics
hypertension
rostafuroxin
Windtree's phase 2 shock med rapidly raises blood pressure—and share price
Fierce Biotech
Wed, 04/20/22 - 11:21 pm
Windtree Therapeutics
cardiogenic shock
istaroxime
Biopharma CEOs on What to Expect at 2021 J.P. Morgan Healthcare Conference
BioSpace
Mon, 01/11/21 - 12:03 am
JPMHC 2021
Pharma CEOs
Windtree Therapeutics
NeuBase
Cerevance